| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 25 | MRK Merck & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 105.26 | 463.139 | 48.75 k | 107,075.674 |
| 1 Dec 25 | MS Morgan Stanley | Common Stock | Grant | Acquire A | No | No | 168.757 | 637.011 | 107.50 k | 121,423.427 |
| 30 Sep 25 | MRK Merck & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 83.93 | 580.841 | 48.75 k | 105,645.897 |
| 30 Jun 25 | MRK Merck & Co. | Phantom Stock Common Stock | Grant | Acquire A | No | No | 79.16 | 615.841 | 48.75 k | 104,040.616 |
| 1 Jun 25 | MS Morgan Stanley | Common Stock | Grant | Acquire A | No | No | 127.5833 | 842.587 | 107.50 k | 119,288.252 |
| 1 Jun 25 | MS Morgan Stanley | Common Stock | Grant | Acquire A | No | No | 0 | 2,155.455 | 0.00 | 118,445.665 |
